Structural basis for antibody inhibition of flavivirus NS1-triggered endothelial dysfunction

Medically important flaviviruses cause diverse disease pathologies and collectively are responsible for a major global disease burden. A contributing factor to pathogenesis is secreted flavivirus nonstructural protein 1 (NS1). Despite demonstrated protection by NS1-specific antibodies against lethal...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Science (American Association for the Advancement of Science) 2021-01, Vol.371 (6525), p.194-200
Hauptverfasser: Biering, Scott B, Akey, David L, Wong, Marcus P, Brown, W Clay, Lo, Nicholas T N, Puerta-Guardo, Henry, Tramontini Gomes de Sousa, Francielle, Wang, Chunling, Konwerski, Jamie R, Espinosa, Diego A, Bockhaus, Nicholas J, Glasner, Dustin R, Li, Jeffrey, Blanc, Sophie F, Juan, Evan Y, Elledge, Stephen J, Mina, Michael J, Beatty, P Robert, Smith, Janet L, Harris, Eva
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 200
container_issue 6525
container_start_page 194
container_title Science (American Association for the Advancement of Science)
container_volume 371
creator Biering, Scott B
Akey, David L
Wong, Marcus P
Brown, W Clay
Lo, Nicholas T N
Puerta-Guardo, Henry
Tramontini Gomes de Sousa, Francielle
Wang, Chunling
Konwerski, Jamie R
Espinosa, Diego A
Bockhaus, Nicholas J
Glasner, Dustin R
Li, Jeffrey
Blanc, Sophie F
Juan, Evan Y
Elledge, Stephen J
Mina, Michael J
Beatty, P Robert
Smith, Janet L
Harris, Eva
description Medically important flaviviruses cause diverse disease pathologies and collectively are responsible for a major global disease burden. A contributing factor to pathogenesis is secreted flavivirus nonstructural protein 1 (NS1). Despite demonstrated protection by NS1-specific antibodies against lethal flavivirus challenge, the structural and mechanistic basis remains unknown. Here, we present three crystal structures of full-length dengue virus NS1 complexed with a flavivirus-cross-reactive, NS1-specific monoclonal antibody, 2B7, at resolutions between 2.89 and 3.96 angstroms. These structures reveal a protective mechanism by which two domains of NS1 are antagonized simultaneously. The NS1 wing domain mediates cell binding, whereas the β-ladder triggers downstream events, both of which are required for dengue, Zika, and West Nile virus NS1-mediated endothelial dysfunction. These observations provide a mechanistic explanation for 2B7 protection against NS1-induced pathology and demonstrate the potential of one antibody to treat infections by multiple flaviviruses.
doi_str_mv 10.1126/science.abc0476
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8000976</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2476559914</sourcerecordid><originalsourceid>FETCH-LOGICAL-c421t-23dcf658e51cc9de3d1323bfee786ddd4555ddea55e05179cc4665d8fbbb60d83</originalsourceid><addsrcrecordid>eNpdkb1PHDEQxa0oKFwgdbpopTRpFuz12rtukBBKQiQEBdBFsvwxvjPas4ntPen--_jCgQLVFPObp3nvIfSZ4BNCOn6ajYdg4ERpg_uBv0MLggVrRYfpe7TAmPJ2xAM7RB9zfsC47gT9gA4p7UnfdXiBft-WNJsyJzU1WmWfGxdTo0LxOtpt48PKa198DE10jZvUxm98mnNzfUvakvxyCQlsA8HGsoLJVxW7zW4OZndzjA6cmjJ82s8jdP_j-93FZXt18_PXxflVa_qOlLaj1jjORmDEGGGBWkI7qh3AMHJrbc8YsxYUY4AZGYQxPefMjk5rzbEd6RE6e9J9nPUarIFQqh_5mPxapa2MysvXm-BXchk3ctxFMvAq8G0vkOKfGXKRa58NTJMKEOcsu5otY0KQvqJf36APcU6h2vtHkVEIRit1-kSZFHNO4F6eIVjumpP75uS-uXrx5X8PL_xzVfQv7z6Z-w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2476189953</pqid></control><display><type>article</type><title>Structural basis for antibody inhibition of flavivirus NS1-triggered endothelial dysfunction</title><source>American Association for the Advancement of Science</source><source>MEDLINE</source><creator>Biering, Scott B ; Akey, David L ; Wong, Marcus P ; Brown, W Clay ; Lo, Nicholas T N ; Puerta-Guardo, Henry ; Tramontini Gomes de Sousa, Francielle ; Wang, Chunling ; Konwerski, Jamie R ; Espinosa, Diego A ; Bockhaus, Nicholas J ; Glasner, Dustin R ; Li, Jeffrey ; Blanc, Sophie F ; Juan, Evan Y ; Elledge, Stephen J ; Mina, Michael J ; Beatty, P Robert ; Smith, Janet L ; Harris, Eva</creator><creatorcontrib>Biering, Scott B ; Akey, David L ; Wong, Marcus P ; Brown, W Clay ; Lo, Nicholas T N ; Puerta-Guardo, Henry ; Tramontini Gomes de Sousa, Francielle ; Wang, Chunling ; Konwerski, Jamie R ; Espinosa, Diego A ; Bockhaus, Nicholas J ; Glasner, Dustin R ; Li, Jeffrey ; Blanc, Sophie F ; Juan, Evan Y ; Elledge, Stephen J ; Mina, Michael J ; Beatty, P Robert ; Smith, Janet L ; Harris, Eva</creatorcontrib><description>Medically important flaviviruses cause diverse disease pathologies and collectively are responsible for a major global disease burden. A contributing factor to pathogenesis is secreted flavivirus nonstructural protein 1 (NS1). Despite demonstrated protection by NS1-specific antibodies against lethal flavivirus challenge, the structural and mechanistic basis remains unknown. Here, we present three crystal structures of full-length dengue virus NS1 complexed with a flavivirus-cross-reactive, NS1-specific monoclonal antibody, 2B7, at resolutions between 2.89 and 3.96 angstroms. These structures reveal a protective mechanism by which two domains of NS1 are antagonized simultaneously. The NS1 wing domain mediates cell binding, whereas the β-ladder triggers downstream events, both of which are required for dengue, Zika, and West Nile virus NS1-mediated endothelial dysfunction. These observations provide a mechanistic explanation for 2B7 protection against NS1-induced pathology and demonstrate the potential of one antibody to treat infections by multiple flaviviruses.</description><identifier>ISSN: 0036-8075</identifier><identifier>EISSN: 1095-9203</identifier><identifier>DOI: 10.1126/science.abc0476</identifier><identifier>PMID: 33414220</identifier><language>eng</language><publisher>United States: The American Association for the Advancement of Science</publisher><subject>Animal models ; Animals ; Antibodies ; Antibodies, Monoclonal - chemistry ; Antibodies, Monoclonal - immunology ; Antibodies, Neutralizing - chemistry ; Antibodies, Neutralizing - immunology ; Antibodies, Viral - chemistry ; Antibodies, Viral - immunology ; Cross Reactions ; Crystal structure ; Crystallography, X-Ray ; Dengue - prevention &amp; control ; Dengue - therapy ; Dengue fever ; Dengue Virus - immunology ; Domains ; Endothelium - immunology ; Epithelial cells ; Flaviviridae ; Glycocalyx - immunology ; Humans ; Infections ; Mice ; Monoclonal antibodies ; NS1 protein ; Pathogenesis ; Protective structures ; Protein Conformation, beta-Strand ; Protein Domains ; Proteins ; Public health ; RNA viruses ; Vaccine development ; Vaccines ; Vector-borne diseases ; Viral envelope proteins ; Viral Nonstructural Proteins - chemistry ; Viral Nonstructural Proteins - immunology ; Viremia ; Viruses ; West Nile Fever - prevention &amp; control ; West Nile Fever - therapy ; West Nile virus ; West Nile virus - immunology ; Zika virus ; Zika Virus - immunology ; Zika Virus Infection - prevention &amp; control ; Zika Virus Infection - therapy</subject><ispartof>Science (American Association for the Advancement of Science), 2021-01, Vol.371 (6525), p.194-200</ispartof><rights>Copyright © 2021, American Association for the Advancement of Science.</rights><rights>Copyright © 2021, American Association for the Advancement of Science</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c421t-23dcf658e51cc9de3d1323bfee786ddd4555ddea55e05179cc4665d8fbbb60d83</citedby><cites>FETCH-LOGICAL-c421t-23dcf658e51cc9de3d1323bfee786ddd4555ddea55e05179cc4665d8fbbb60d83</cites><orcidid>0000-0001-6554-2976 ; 0000-0002-7238-4037 ; 0000-0001-9821-6683 ; 0000-0002-0664-9228 ; 0000-0002-0674-5762 ; 0000-0003-3746-1751 ; 0000-0002-3168-0278 ; 0000-0002-9341-1014 ; 0000-0002-4364-5031 ; 0000-0003-1991-629X ; 0000-0001-9691-0663 ; 0000-0003-1645-2880 ; 0000-0002-5687-540X ; 0000-0003-3050-4480 ; 0000-0002-9550-1590 ; 0000-0001-7923-6283</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,2871,2872,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33414220$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Biering, Scott B</creatorcontrib><creatorcontrib>Akey, David L</creatorcontrib><creatorcontrib>Wong, Marcus P</creatorcontrib><creatorcontrib>Brown, W Clay</creatorcontrib><creatorcontrib>Lo, Nicholas T N</creatorcontrib><creatorcontrib>Puerta-Guardo, Henry</creatorcontrib><creatorcontrib>Tramontini Gomes de Sousa, Francielle</creatorcontrib><creatorcontrib>Wang, Chunling</creatorcontrib><creatorcontrib>Konwerski, Jamie R</creatorcontrib><creatorcontrib>Espinosa, Diego A</creatorcontrib><creatorcontrib>Bockhaus, Nicholas J</creatorcontrib><creatorcontrib>Glasner, Dustin R</creatorcontrib><creatorcontrib>Li, Jeffrey</creatorcontrib><creatorcontrib>Blanc, Sophie F</creatorcontrib><creatorcontrib>Juan, Evan Y</creatorcontrib><creatorcontrib>Elledge, Stephen J</creatorcontrib><creatorcontrib>Mina, Michael J</creatorcontrib><creatorcontrib>Beatty, P Robert</creatorcontrib><creatorcontrib>Smith, Janet L</creatorcontrib><creatorcontrib>Harris, Eva</creatorcontrib><title>Structural basis for antibody inhibition of flavivirus NS1-triggered endothelial dysfunction</title><title>Science (American Association for the Advancement of Science)</title><addtitle>Science</addtitle><description>Medically important flaviviruses cause diverse disease pathologies and collectively are responsible for a major global disease burden. A contributing factor to pathogenesis is secreted flavivirus nonstructural protein 1 (NS1). Despite demonstrated protection by NS1-specific antibodies against lethal flavivirus challenge, the structural and mechanistic basis remains unknown. Here, we present three crystal structures of full-length dengue virus NS1 complexed with a flavivirus-cross-reactive, NS1-specific monoclonal antibody, 2B7, at resolutions between 2.89 and 3.96 angstroms. These structures reveal a protective mechanism by which two domains of NS1 are antagonized simultaneously. The NS1 wing domain mediates cell binding, whereas the β-ladder triggers downstream events, both of which are required for dengue, Zika, and West Nile virus NS1-mediated endothelial dysfunction. These observations provide a mechanistic explanation for 2B7 protection against NS1-induced pathology and demonstrate the potential of one antibody to treat infections by multiple flaviviruses.</description><subject>Animal models</subject><subject>Animals</subject><subject>Antibodies</subject><subject>Antibodies, Monoclonal - chemistry</subject><subject>Antibodies, Monoclonal - immunology</subject><subject>Antibodies, Neutralizing - chemistry</subject><subject>Antibodies, Neutralizing - immunology</subject><subject>Antibodies, Viral - chemistry</subject><subject>Antibodies, Viral - immunology</subject><subject>Cross Reactions</subject><subject>Crystal structure</subject><subject>Crystallography, X-Ray</subject><subject>Dengue - prevention &amp; control</subject><subject>Dengue - therapy</subject><subject>Dengue fever</subject><subject>Dengue Virus - immunology</subject><subject>Domains</subject><subject>Endothelium - immunology</subject><subject>Epithelial cells</subject><subject>Flaviviridae</subject><subject>Glycocalyx - immunology</subject><subject>Humans</subject><subject>Infections</subject><subject>Mice</subject><subject>Monoclonal antibodies</subject><subject>NS1 protein</subject><subject>Pathogenesis</subject><subject>Protective structures</subject><subject>Protein Conformation, beta-Strand</subject><subject>Protein Domains</subject><subject>Proteins</subject><subject>Public health</subject><subject>RNA viruses</subject><subject>Vaccine development</subject><subject>Vaccines</subject><subject>Vector-borne diseases</subject><subject>Viral envelope proteins</subject><subject>Viral Nonstructural Proteins - chemistry</subject><subject>Viral Nonstructural Proteins - immunology</subject><subject>Viremia</subject><subject>Viruses</subject><subject>West Nile Fever - prevention &amp; control</subject><subject>West Nile Fever - therapy</subject><subject>West Nile virus</subject><subject>West Nile virus - immunology</subject><subject>Zika virus</subject><subject>Zika Virus - immunology</subject><subject>Zika Virus Infection - prevention &amp; control</subject><subject>Zika Virus Infection - therapy</subject><issn>0036-8075</issn><issn>1095-9203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkb1PHDEQxa0oKFwgdbpopTRpFuz12rtukBBKQiQEBdBFsvwxvjPas4ntPen--_jCgQLVFPObp3nvIfSZ4BNCOn6ajYdg4ERpg_uBv0MLggVrRYfpe7TAmPJ2xAM7RB9zfsC47gT9gA4p7UnfdXiBft-WNJsyJzU1WmWfGxdTo0LxOtpt48PKa198DE10jZvUxm98mnNzfUvakvxyCQlsA8HGsoLJVxW7zW4OZndzjA6cmjJ82s8jdP_j-93FZXt18_PXxflVa_qOlLaj1jjORmDEGGGBWkI7qh3AMHJrbc8YsxYUY4AZGYQxPefMjk5rzbEd6RE6e9J9nPUarIFQqh_5mPxapa2MysvXm-BXchk3ctxFMvAq8G0vkOKfGXKRa58NTJMKEOcsu5otY0KQvqJf36APcU6h2vtHkVEIRit1-kSZFHNO4F6eIVjumpP75uS-uXrx5X8PL_xzVfQv7z6Z-w</recordid><startdate>20210108</startdate><enddate>20210108</enddate><creator>Biering, Scott B</creator><creator>Akey, David L</creator><creator>Wong, Marcus P</creator><creator>Brown, W Clay</creator><creator>Lo, Nicholas T N</creator><creator>Puerta-Guardo, Henry</creator><creator>Tramontini Gomes de Sousa, Francielle</creator><creator>Wang, Chunling</creator><creator>Konwerski, Jamie R</creator><creator>Espinosa, Diego A</creator><creator>Bockhaus, Nicholas J</creator><creator>Glasner, Dustin R</creator><creator>Li, Jeffrey</creator><creator>Blanc, Sophie F</creator><creator>Juan, Evan Y</creator><creator>Elledge, Stephen J</creator><creator>Mina, Michael J</creator><creator>Beatty, P Robert</creator><creator>Smith, Janet L</creator><creator>Harris, Eva</creator><general>The American Association for the Advancement of Science</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QF</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QQ</scope><scope>7QR</scope><scope>7SC</scope><scope>7SE</scope><scope>7SN</scope><scope>7SP</scope><scope>7SR</scope><scope>7SS</scope><scope>7T7</scope><scope>7TA</scope><scope>7TB</scope><scope>7TK</scope><scope>7TM</scope><scope>7U5</scope><scope>7U9</scope><scope>8BQ</scope><scope>8FD</scope><scope>C1K</scope><scope>F28</scope><scope>FR3</scope><scope>H8D</scope><scope>H8G</scope><scope>H94</scope><scope>JG9</scope><scope>JQ2</scope><scope>K9.</scope><scope>KR7</scope><scope>L7M</scope><scope>L~C</scope><scope>L~D</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-6554-2976</orcidid><orcidid>https://orcid.org/0000-0002-7238-4037</orcidid><orcidid>https://orcid.org/0000-0001-9821-6683</orcidid><orcidid>https://orcid.org/0000-0002-0664-9228</orcidid><orcidid>https://orcid.org/0000-0002-0674-5762</orcidid><orcidid>https://orcid.org/0000-0003-3746-1751</orcidid><orcidid>https://orcid.org/0000-0002-3168-0278</orcidid><orcidid>https://orcid.org/0000-0002-9341-1014</orcidid><orcidid>https://orcid.org/0000-0002-4364-5031</orcidid><orcidid>https://orcid.org/0000-0003-1991-629X</orcidid><orcidid>https://orcid.org/0000-0001-9691-0663</orcidid><orcidid>https://orcid.org/0000-0003-1645-2880</orcidid><orcidid>https://orcid.org/0000-0002-5687-540X</orcidid><orcidid>https://orcid.org/0000-0003-3050-4480</orcidid><orcidid>https://orcid.org/0000-0002-9550-1590</orcidid><orcidid>https://orcid.org/0000-0001-7923-6283</orcidid></search><sort><creationdate>20210108</creationdate><title>Structural basis for antibody inhibition of flavivirus NS1-triggered endothelial dysfunction</title><author>Biering, Scott B ; Akey, David L ; Wong, Marcus P ; Brown, W Clay ; Lo, Nicholas T N ; Puerta-Guardo, Henry ; Tramontini Gomes de Sousa, Francielle ; Wang, Chunling ; Konwerski, Jamie R ; Espinosa, Diego A ; Bockhaus, Nicholas J ; Glasner, Dustin R ; Li, Jeffrey ; Blanc, Sophie F ; Juan, Evan Y ; Elledge, Stephen J ; Mina, Michael J ; Beatty, P Robert ; Smith, Janet L ; Harris, Eva</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c421t-23dcf658e51cc9de3d1323bfee786ddd4555ddea55e05179cc4665d8fbbb60d83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Animal models</topic><topic>Animals</topic><topic>Antibodies</topic><topic>Antibodies, Monoclonal - chemistry</topic><topic>Antibodies, Monoclonal - immunology</topic><topic>Antibodies, Neutralizing - chemistry</topic><topic>Antibodies, Neutralizing - immunology</topic><topic>Antibodies, Viral - chemistry</topic><topic>Antibodies, Viral - immunology</topic><topic>Cross Reactions</topic><topic>Crystal structure</topic><topic>Crystallography, X-Ray</topic><topic>Dengue - prevention &amp; control</topic><topic>Dengue - therapy</topic><topic>Dengue fever</topic><topic>Dengue Virus - immunology</topic><topic>Domains</topic><topic>Endothelium - immunology</topic><topic>Epithelial cells</topic><topic>Flaviviridae</topic><topic>Glycocalyx - immunology</topic><topic>Humans</topic><topic>Infections</topic><topic>Mice</topic><topic>Monoclonal antibodies</topic><topic>NS1 protein</topic><topic>Pathogenesis</topic><topic>Protective structures</topic><topic>Protein Conformation, beta-Strand</topic><topic>Protein Domains</topic><topic>Proteins</topic><topic>Public health</topic><topic>RNA viruses</topic><topic>Vaccine development</topic><topic>Vaccines</topic><topic>Vector-borne diseases</topic><topic>Viral envelope proteins</topic><topic>Viral Nonstructural Proteins - chemistry</topic><topic>Viral Nonstructural Proteins - immunology</topic><topic>Viremia</topic><topic>Viruses</topic><topic>West Nile Fever - prevention &amp; control</topic><topic>West Nile Fever - therapy</topic><topic>West Nile virus</topic><topic>West Nile virus - immunology</topic><topic>Zika virus</topic><topic>Zika Virus - immunology</topic><topic>Zika Virus Infection - prevention &amp; control</topic><topic>Zika Virus Infection - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Biering, Scott B</creatorcontrib><creatorcontrib>Akey, David L</creatorcontrib><creatorcontrib>Wong, Marcus P</creatorcontrib><creatorcontrib>Brown, W Clay</creatorcontrib><creatorcontrib>Lo, Nicholas T N</creatorcontrib><creatorcontrib>Puerta-Guardo, Henry</creatorcontrib><creatorcontrib>Tramontini Gomes de Sousa, Francielle</creatorcontrib><creatorcontrib>Wang, Chunling</creatorcontrib><creatorcontrib>Konwerski, Jamie R</creatorcontrib><creatorcontrib>Espinosa, Diego A</creatorcontrib><creatorcontrib>Bockhaus, Nicholas J</creatorcontrib><creatorcontrib>Glasner, Dustin R</creatorcontrib><creatorcontrib>Li, Jeffrey</creatorcontrib><creatorcontrib>Blanc, Sophie F</creatorcontrib><creatorcontrib>Juan, Evan Y</creatorcontrib><creatorcontrib>Elledge, Stephen J</creatorcontrib><creatorcontrib>Mina, Michael J</creatorcontrib><creatorcontrib>Beatty, P Robert</creatorcontrib><creatorcontrib>Smith, Janet L</creatorcontrib><creatorcontrib>Harris, Eva</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Aluminium Industry Abstracts</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Ceramic Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Computer and Information Systems Abstracts</collection><collection>Corrosion Abstracts</collection><collection>Ecology Abstracts</collection><collection>Electronics &amp; Communications Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Materials Business File</collection><collection>Mechanical &amp; Transportation Engineering Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ANTE: Abstracts in New Technology &amp; Engineering</collection><collection>Engineering Research Database</collection><collection>Aerospace Database</collection><collection>Copper Technical Reference Library</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Materials Research Database</collection><collection>ProQuest Computer Science Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Civil Engineering Abstracts</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Computer and Information Systems Abstracts – Academic</collection><collection>Computer and Information Systems Abstracts Professional</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Science (American Association for the Advancement of Science)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Biering, Scott B</au><au>Akey, David L</au><au>Wong, Marcus P</au><au>Brown, W Clay</au><au>Lo, Nicholas T N</au><au>Puerta-Guardo, Henry</au><au>Tramontini Gomes de Sousa, Francielle</au><au>Wang, Chunling</au><au>Konwerski, Jamie R</au><au>Espinosa, Diego A</au><au>Bockhaus, Nicholas J</au><au>Glasner, Dustin R</au><au>Li, Jeffrey</au><au>Blanc, Sophie F</au><au>Juan, Evan Y</au><au>Elledge, Stephen J</au><au>Mina, Michael J</au><au>Beatty, P Robert</au><au>Smith, Janet L</au><au>Harris, Eva</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Structural basis for antibody inhibition of flavivirus NS1-triggered endothelial dysfunction</atitle><jtitle>Science (American Association for the Advancement of Science)</jtitle><addtitle>Science</addtitle><date>2021-01-08</date><risdate>2021</risdate><volume>371</volume><issue>6525</issue><spage>194</spage><epage>200</epage><pages>194-200</pages><issn>0036-8075</issn><eissn>1095-9203</eissn><abstract>Medically important flaviviruses cause diverse disease pathologies and collectively are responsible for a major global disease burden. A contributing factor to pathogenesis is secreted flavivirus nonstructural protein 1 (NS1). Despite demonstrated protection by NS1-specific antibodies against lethal flavivirus challenge, the structural and mechanistic basis remains unknown. Here, we present three crystal structures of full-length dengue virus NS1 complexed with a flavivirus-cross-reactive, NS1-specific monoclonal antibody, 2B7, at resolutions between 2.89 and 3.96 angstroms. These structures reveal a protective mechanism by which two domains of NS1 are antagonized simultaneously. The NS1 wing domain mediates cell binding, whereas the β-ladder triggers downstream events, both of which are required for dengue, Zika, and West Nile virus NS1-mediated endothelial dysfunction. These observations provide a mechanistic explanation for 2B7 protection against NS1-induced pathology and demonstrate the potential of one antibody to treat infections by multiple flaviviruses.</abstract><cop>United States</cop><pub>The American Association for the Advancement of Science</pub><pmid>33414220</pmid><doi>10.1126/science.abc0476</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0001-6554-2976</orcidid><orcidid>https://orcid.org/0000-0002-7238-4037</orcidid><orcidid>https://orcid.org/0000-0001-9821-6683</orcidid><orcidid>https://orcid.org/0000-0002-0664-9228</orcidid><orcidid>https://orcid.org/0000-0002-0674-5762</orcidid><orcidid>https://orcid.org/0000-0003-3746-1751</orcidid><orcidid>https://orcid.org/0000-0002-3168-0278</orcidid><orcidid>https://orcid.org/0000-0002-9341-1014</orcidid><orcidid>https://orcid.org/0000-0002-4364-5031</orcidid><orcidid>https://orcid.org/0000-0003-1991-629X</orcidid><orcidid>https://orcid.org/0000-0001-9691-0663</orcidid><orcidid>https://orcid.org/0000-0003-1645-2880</orcidid><orcidid>https://orcid.org/0000-0002-5687-540X</orcidid><orcidid>https://orcid.org/0000-0003-3050-4480</orcidid><orcidid>https://orcid.org/0000-0002-9550-1590</orcidid><orcidid>https://orcid.org/0000-0001-7923-6283</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0036-8075
ispartof Science (American Association for the Advancement of Science), 2021-01, Vol.371 (6525), p.194-200
issn 0036-8075
1095-9203
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8000976
source American Association for the Advancement of Science; MEDLINE
subjects Animal models
Animals
Antibodies
Antibodies, Monoclonal - chemistry
Antibodies, Monoclonal - immunology
Antibodies, Neutralizing - chemistry
Antibodies, Neutralizing - immunology
Antibodies, Viral - chemistry
Antibodies, Viral - immunology
Cross Reactions
Crystal structure
Crystallography, X-Ray
Dengue - prevention & control
Dengue - therapy
Dengue fever
Dengue Virus - immunology
Domains
Endothelium - immunology
Epithelial cells
Flaviviridae
Glycocalyx - immunology
Humans
Infections
Mice
Monoclonal antibodies
NS1 protein
Pathogenesis
Protective structures
Protein Conformation, beta-Strand
Protein Domains
Proteins
Public health
RNA viruses
Vaccine development
Vaccines
Vector-borne diseases
Viral envelope proteins
Viral Nonstructural Proteins - chemistry
Viral Nonstructural Proteins - immunology
Viremia
Viruses
West Nile Fever - prevention & control
West Nile Fever - therapy
West Nile virus
West Nile virus - immunology
Zika virus
Zika Virus - immunology
Zika Virus Infection - prevention & control
Zika Virus Infection - therapy
title Structural basis for antibody inhibition of flavivirus NS1-triggered endothelial dysfunction
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T01%3A10%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Structural%20basis%20for%20antibody%20inhibition%20of%20flavivirus%20NS1-triggered%20endothelial%20dysfunction&rft.jtitle=Science%20(American%20Association%20for%20the%20Advancement%20of%20Science)&rft.au=Biering,%20Scott%20B&rft.date=2021-01-08&rft.volume=371&rft.issue=6525&rft.spage=194&rft.epage=200&rft.pages=194-200&rft.issn=0036-8075&rft.eissn=1095-9203&rft_id=info:doi/10.1126/science.abc0476&rft_dat=%3Cproquest_pubme%3E2476559914%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2476189953&rft_id=info:pmid/33414220&rfr_iscdi=true